Gage et al., 2000 - Google Patents
Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formationGage et al., 2000
- Document ID
- 5186052361024680528
- Author
- Gage R
- Venn R
- Bayliss M
- Edgington A
- Roffey S
- Sorrell B
- Publication year
- Publication venue
- Journal of pharmaceutical and biomedical analysis
External Links
Snippet
A selective method for the determination of sulphobutylether-β-cyclodextrin (SBECD) in human plasma has been developed and validated over the range 4–200 μg ml− 1. SBECD is extracted from plasma using end-capped cyclohexyl solid phase extraction cartridges …
- 210000002381 Plasma 0 title abstract description 44
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zaspel et al. | Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography | |
| Archontaki et al. | Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins | |
| KOIZUMI et al. | Inclusion complexes of poorly water-soluble drugs with glucosyl-cyclodextrins | |
| Carando et al. | Comparison of (+)-catechin determination in human plasma by high-performance liquid chromatography with two types of detection: fluorescence and ultraviolet | |
| Cheng et al. | Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography | |
| Cheng et al. | A validated LC–MS/MS determination method for the illegal food additive rhodamine B: Applications of a pharmacokinetic study in rats | |
| Gallego et al. | Spectrophotometric determination of hydrocortisone, nystatin and oxytetracycline in synthetic and pharmaceutical preparations based on various univariate and multivariate methods | |
| Dunnett et al. | Reverse-phase ion-pairing high-performance liquid chromatography of phosphocreatine, creatine and creatinine in equine muscle | |
| Sandall et al. | Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples | |
| Zhang et al. | Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction | |
| Gage et al. | Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation | |
| Bunch et al. | A fast and simple assay for busulfan in serum or plasma by liquid chromatography–tandem mass spectrometry using turbulent flow online extraction technology | |
| KR20130076892A (en) | Highly sensitive method of determining the quantity of herbal medicine-derived components | |
| Lesko et al. | High‐pressure liquid chromatography of amiodarone in biological fluids | |
| Bose et al. | Amitriptyline and nortriptyline serum determination by micellar liquid chromatography | |
| Brouwer et al. | Linearized colorimetric assay for Cremophor EL: application to pharmacokinetics after 1-hour paclitaxel infusions | |
| Saleh et al. | Kinetic spectrophotometric determination of certain cephalosporins using oxidized quercetin reagent | |
| Zaffaroni et al. | High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma | |
| Cai et al. | Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection | |
| Jain et al. | Simultaneous estimation of ofloxacin and tinidazole in solid dosage form by uv-spectrophotometry using mixed solvency concept | |
| Mukker et al. | HPLC method with fluorescence detection for the quantitative determination of flaxseed lignans | |
| Bosáková et al. | Study of the stability of promethazine enantiomers by liquid chromatography using a vancomycin-bonded chiral stationary phase | |
| González-Peñas et al. | A sensitive method for the determination of gemfibrozil in human plasma samples by RP-LC | |
| Štěpánová et al. | Separation of rotamers of 5-nitrosopyrimidines and estimation of binding constants of their complexes with β-cyclodextrin by capillary electrophoresis | |
| Ahmad et al. | Development and validation of RP-HPLC method for simultaneous estimation of glibenclamide and thymoquinone in rat plasma and its application to pharmacokinetics |